Cytogenetic effects of ciprofloxacin (500 to 2,000 mg daily) and ofloxacin (200 mg daily) were studied in lymphocytes from 31 patients treated for 1 to 10 weeks. Blood samples for cytogenetic analysis were taken before the start of treatment from all patients, after 1 week from 25 patients, and after 2, 4, 6, and 10 weeks from six patients. No chromosome-damaging effect could be demonstrated in any treatment group. The mean aberration yields for each cytogenetic parameter studied and the total number of aberrations were all normal at each sampling occasion.
Ciprofloxacin, norfloxacin, and ofloxacin are new quinolone derivatives which are structurally related to nalidixic acid but far more bactericidal; they are active against a wide range of gram-positive and gram-negative bacteria. The new 4-quinolones bind to DNA (9) and significantly increase the incorporation of [3H]thymidine into the DNA of mitogenstimulated human lymphocytes (1) (2) (3) , indicating a stimulation of DNA synthesis in vitro. It has also been suggested that the quinolones may affect de novo pyrimidine biosynthesis and at high concentrations inhibit cell growth in vitro (2) No significant differences were found in the mean yield of any aberration type or of the total number of aberrations between before and after 1 week of treatment with either ciprofloxacin or ofloxacin (Table 1 ). There were no differences in cytogenetic effects between the two treatment groups for any of the individual parameters or for the total number of aberrations. Neither were there any significant differences for any aberration type or combination of aberration types among the five sampling occasions for those patients who received a much higher ciprofloxacin dose (1,500 to 2,000 mg daily) for 10 weeks (Table 2 ). In both the short-term and long-term-treated patient groups, the mean aberration frequencies of each cytogenetic parameter studied as well as the total number of aberrations were all within the normal limits of our laboratory (4) (5) (6) 8) .
The present study confirms results recently presented by Forsgren et al. (2), who found no increase in chromosome damage or DNA-strand breaks in lymphocytes incubated with up to 25 ,ug of ciprofloxacin per ml. Our results add the information that no chromosome-damaging effect can be observed in vivo with clinically used dosages even after long-term treatment. 
